Press release
Next-Generation Gynecological Cancer Diagnostics Market 2024 - By Size, Share Analysis, Trends And Growth Forecast By 2033
Next-Generation Gynecological Cancer Diagnostics Market
As per the report, the next-generation gynecological cancer diagnostics market size has grown rapidly in recent years. It will grow from $2.39 billion in 2023 to $2.68 billion in 2024 at a compound annual growth rate (CAGR) of 12.3%. The next-generation gynecological cancer diagnostics market size is expected to see rapid growth in the next few years. It will grow to $4.07 billion in 2028 at a compound annual growth rate (CAGR) of 11.0%.
Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=12020&type=smp
Surging Prevalence Of Gynecological Malignancies To Drive Market Growth
The rising prevalence of gynecological malignancies is expected to propel the growth of the next-generation gynecological cancer diagnostics market. Gynecological malignancies refer to cancers that occur in the reproductive organs of females, such as the cervix, uterus, ovaries, fallopian tubes, and vu*lva. The next-generation gynecological cancer diagnostics help reduce gynecological malignancies by allowing for earlier detection of cancerous cells, facilitating targeted treatments, and improving overall patient outcomes. For Instance, in February 2023, according to the National Cancer Institute, a US-based Department of Health and Human Services, around 13,960 American women are anticipated to have an aggressive cervical cancer diagnosis, and 4,310 fatalities from this illness are expected in 2023 in the US. Further, 7.7 per 100,000 women per year new cases of cervical cancer were diagnosed, with an annual death rate of 2.2 per 100,000 females. Therefore, the rising prevalence of gynecological malignancies is driving the growth of the next-generation gynecological cancer diagnostics market.
Product Innovations Transforming The Next-Generation Gynecological Cancer Diagnostics Market
Major companies operating in the next-generation gynecological cancer diagnostics market are developing new products such as AI-enabled women's health ultrasound systems to gain a competitive edge in the market. An ultrasound system is a medical imaging device that utilizes high-frequency sound waves to create visual representations of the internal structures of the body. For instance, in February 2023, Samsung Electronics Co. Ltd., a South Korea-based consumer electronics company, launched the HERA W10 Elite, a new women's health ultrasound system that leverages artificial intelligence (AI)-aided tools and clinical applications for Obstetrics and Gynecology. The HERA W10 Elite provides advanced 2D and 3D visualizations of microcirculatory and slow blood. The ultrasound system features an Advanced MV-Flow feature, a larger organic light-emitting diode (OLED) display, and enhanced AI capabilities such as HeartAssist, ViewAssist, and BiometryAssist. Designed for greater diagnostic insight, the HERA W10 Elite aims to bring visionary change to the field of Obstetrics and Gynecology with sophisticated image processing and an ergonomic-friendly design.
The next-generation gynecological cancer diagnostics market covered in this report is segmented -
1) By Cancer Type: Cervical Cancer, Ovarian Cancer, Uterine Cancer, Vaginal Cancer, Vulv*ar Cancer
2) By Function: Therapeutic Monitoring, Companion Diagnostics, Prognostics, Cancer Screening, Risk Analysis
3) By Technology: Next-Generation Sequencing, qPCR And Multiplexing, Lab-on- a- chip (LOAC) And Reverse Transcriptase-PCR (RT-PCR), Protein Microarrays, DNA Microarrays
4) By Application: Biomarker Development, CTC Analysis, Proteomic Analysis, Epigenetic Analysis, Genetic Analysis
5) By End User: Hospitals and Ambulatory Centers, Diagnostic Laboratories, Academic and Research Institutes
Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=12020&type=discount
Major companies operating in the next-generation gynecological cancer diagnostics market report are F. Hoffmann-La Roche Ltd., AbbVie Inc., Novartis AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Janssen Global Services LLC, Siemens Healthcare GmbH, Agena Bioscience Inc., Koninklijke Philips N.V., Becton, Dickinson and Company, GE HealthCare Technologies Inc., Laboratory Corporation Of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Konica Minolta Inc., Hologic Inc., Illumina Inc., PerkinElmer Inc., Sysmex Corporation, Qiagen N.V., ARUP Laboratories, Almac Group, BGI Genomics Co Ltd, OPKO HEALTH Inc., BGI Genomics Co. Ltd., Myriad Genetics Inc., Fulgent Genetics Inc., Cepheid, Invitae Corporation, Centogene NV
Contents of the report:
1. Executive Summary
2. Next-Generation Gynecological Cancer Diagnostics Market Report Structure
3. Next-Generation Gynecological Cancer Diagnostics Market Trends And Strategies
4. Next-Generation Gynecological Cancer Diagnostics Market - Macro Economic Scenario
5. Next-Generation Gynecological Cancer Diagnostics Market Size And Growth
…..
27. Next-Generation Gynecological Cancer Diagnostics Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/next-generation-gynecological-cancer-diagnostics-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Next-Generation Gynecological Cancer Diagnostics Market 2024 - By Size, Share Analysis, Trends And Growth Forecast By 2033 here
News-ID: 3591608 • Views: …
More Releases from The Business research company
Leading Companies Fueling Growth and Innovation in the Cross-Sell and Upsell Art …
The cross-sell and upsell artificial intelligence (AI) market is on the brink of rapid expansion, driven by the increasing need for smarter sales strategies and personalized customer experiences. This sector is set to transform how businesses engage with consumers, leveraging AI technologies to enhance revenue streams and optimize customer journeys. Let's explore the market's size, key players, emerging trends, and the segmentation that define this growing industry.
Forecasted Growth in the…
Cloud-Managed Local Area Network (LAN) Market Overview: Major Segments, Strategi …
The cloud-managed local area network (LAN) market is set for impressive growth over the coming years, driven by technological advancements and changing business needs. As organizations increasingly adopt cloud-first approaches and remote work continues to expand, this market is poised to reach significant valuation milestones by 2030. Let's explore the market's projected size, key players, emerging trends, and detailed segment analysis to understand the future direction of cloud-managed LAN solutions.
Expected…
Analysis of Segments and Major Growth Areas in the Cloud Native Applications Mar …
The cloud native applications market is on track for significant expansion as businesses increasingly adopt cloud-first strategies and seek agility in software development. This sector is rapidly evolving with innovations that enable faster delivery, improved security, and seamless management of applications across diverse cloud environments. Let's explore the market's size projections, key players, trends driving growth, and important segmentations shaping its future.
Projected Size and Growth Trajectory of the Cloud Native…
Key Strategic Developments and Emerging Changes Shaping the Cloud Computing Land …
The education technology sector is undergoing a remarkable transformation, largely fueled by the rapid adoption of cloud computing. As institutions embrace digital solutions, the integration of cloud-based tools is reshaping teaching and learning methods. This evolution promises significant market growth and new opportunities through 2030.
Cloud Computing in Education Technology Market Size and Growth Outlook
The cloud computing segment within education technology is projected to experience explosive growth, reaching a…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
